When EGFR TKI blocks EGFR signaling related proliferation and differentiation of type II alveolar cells, these cells transform to SCLC if additional key genetic events such as RB1 inactivation occurs [29]. The gene discussed is EGFR; the disease is small cell lung carcinoma.